Self-reported data on medicine use in the Norwegian mother and child cohort study compared to data from the Norwegian prescription database

Norsk Epidemiologi

Volumn 24, Issue 1-2, 2014, Pages 209-216

  Skurtveit, Svetlana ^a,b   Selmer, Randi ^a   Odsbu, Ingvild ^a   Handal, Marte ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; OPIATE; PRESCRIPTION DRUG;

ADULT; ANXIETY DISORDER; ARTICLE; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG USE; FEMALE; HUMAN; MEDICAL INFORMATION; MOTHER; NORWAY; NORWEGIAN PRESCRIPTION DATABASE; PREGNANCY; PREGNANT WOMAN; QUESTIONNAIRE; SELF REPORT; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

EID: 84919968234     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: 10.5324/nje.v24i1-2.1824     Document Type: Article

References (22)

1. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004; 191 (2): 398-407.
2. Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol 2008; 65 (5): 653-60.
3. Lee E, Maneno MK, Smith L, et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf 2006; 15 (8): 537-45.
4. Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol 2011; 3: 43-50.
5. Espnes MG, Bjørge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2011; 20 (3): 243-8.
6. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010; 106 (2): 86-94.
7. Skurtveit S, Selmer R, Tverdal A, Furu K, Nystad W, Handal M. Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations. J Clin Epidemiol 2013; 66 (9): 964-72.
8. Kallen B, Nilsson E, Olausson PO. Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records. Eur J Clin Pharmacol 2011; 67 (8): 839-45.
9. Kieler H, Artama M, Engeland A, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012; 344: d8012.
10. Koren G, Nordeng H. SSRIs and persistent pulmonary hypertension of the newborn. BMJ 2012; 344: d7642.
11. Magnus P, Irgens LM, Haug K, Nystad W, Skjærven R, Stoltenberg C. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 2006; 35 (5): 1146-50.
12. Irgens LM. The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000; 79 (6): 435-9.
13. WHO Collaborating Centre for Drug Statistics Methodology. ATC Classification Index with DDDs 2013. WHO Collaborating Center for Drug Statistics Methodology, 2012.
14. Questionnaires from MoBa. Norwegian Institute of Public Health. http://www.fhi.no/eway/default.aspx?pid=240&trg=MainContent_6894&Main_6664=6894:0:25,7372:1:0:0::: 0:0&MainContent_6894=6706:0:25,7375:1:0:0:::0:0. Accessed 17.03 2014.
15. Grzeskowiak LE, Gilbert AL, Morrison JL. Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy. Eur J Clin Pharmacol 2012; 68 (5): 459-67.
16. Vollset SE. Confidence intervals for a binomial proportion. Stat Med 1993; 12 (9): 809-24.
17. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol 1996; 25 (6):1107-16.
18. Validity of pharmacoepidemiologic drug and diagnosis data. In: Strom BL, ed. Pharmacoepidemiology, 4th edn. Chichester: John Wiley & Sons; 2006: 709-765.
19. Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 1986; 123 (4): 670-6.
20. Nilsen RM, Vollset SE, Gjessing HK, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 2009; 23 (6): 597-608.
21. Handal M, Engeland A, Rønning M, Skurtveit S, Furu K. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. Eur J Clin Pharmacol 2011; 67: 953-60.
22. Olesen C, Søndergaard C, Thrane N, Nielsen GL, de jong-van den Berg L, Olsen J. Do pregnant women report use of dispensed medications? Epidemiology 2001; 12 (5): 497-501